ClinicalTrials.Veeva

Menu

Evaluation of Hydration Status When Consuming Alkaline Water Compared to Reverse Osmosis Purified Water.

N

Natural Immune Systems

Status

Completed

Conditions

Hydration

Treatments

Dietary Supplement: Reverse osmosis water
Dietary Supplement: Alkaline water

Study type

Interventional

Funder types

Other

Identifiers

NCT04460846
NIS165-003

Details and patient eligibility

About

To conduct a randomized, double-blinded, placebo-controlled, cross-over trial in a population of chronically, moderately dehydrated people comparing two waters on hydration status.

Full description

A randomized, double-blinded, placebo-controlled cross-over study design will be used to evaluate the effects of consumption of alkaline water against reverse osmosis water. The study is of 5 weeks' duration, with evaluation at baseline, 2 weeks (beginning of wash-out period), 3 weeks (end of wash-out period), and 5 weeks.

Enrollment

12 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult people of either gender;

  • Age 18 - 65 years (inclusive);

  • BMI between 18.0 and 34.9 (inclusive);

  • Screening results showing at least one of the following:

    • Hematocrit: Women: 45.0 or higher; Men: 48.7 or higher;
    • BUN/Creatinine ratio 20 or higher;
    • Sodium levels 146 mmol/L or higher;
    • Potassium levels 5.3 mmol/L or higher;
    • Chloride levels 108 mmol/L or higher.
  • Willing to maintain a consistent diet (including medications, vitamins and supplements) and lifestyle routine throughout the study;

  • Willing to abstain from coffee, tea, soft drinks, and nicotine for at least one hour prior to a clinic visit;

  • Willing to abstain from alcohol for at least 12 hours prior to a clinic visit;

  • Willing to maintain a consistent habit of abstaining from exercising and nutritional supplements on the morning of a study visit.

Exclusion criteria

  • Cancer during past 12 months;
  • Chemotherapy during past 12 months;
  • Significant active uncontrolled illness (such as lymphoma, liver disease, kidney failure, heart failure).
  • Previous major surgery to stomach or intestines [(absorption of test product may be altered) minor surgery is not a problem, including appendix and gallbladder removal];
  • Implanted electronic device such as pacemaker or implantable cardioverter-defibrillator (ICD);
  • Currently experiencing peripheral edema in legs and /or feet;
  • Diagnosed with any blood clotting disorder or taking clotting factor concentrates;
  • Diagnosis of Peripheral Artery Disease;
  • Diagnosis of varicose veins;
  • Currently taking blood pressure medication;
  • Currently taking blood thinning medication (81mg aspirin allowed);
  • Currently taking diuretic medication;
  • Currently taking nutritional supplements and other substances judged by the study coordinator to negate or camouflage the effects of the test product;
  • Women who are pregnant, nursing, or trying to become pregnant.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

12 participants in 2 patient groups, including a placebo group

Alkaline water
Active Comparator group
Description:
Participants will consume 1.5 liters per day
Treatment:
Dietary Supplement: Alkaline water
Reverse osmosis water
Placebo Comparator group
Description:
Participants will consume 1.5 liters per day
Treatment:
Dietary Supplement: Reverse osmosis water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems